| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 5.93e-05 | 11 | 145 | 3 | GO:0004143 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 1.77e-04 | 161 | 145 | 7 | GO:0051087 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ATP7A ITGA6 TOGARAM1 SAXO1 SH2B1 DNALI1 C2CD3 ALMS1 ARHGEF7 ANO6 RP1L1 PKHD1 KCNQ1 COBL PLD1 CPLANE1 ARHGEF6 | 4.13e-06 | 670 | 143 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | ATP7A ITGA6 TOGARAM1 SAXO1 SH2B1 DNALI1 C2CD3 ALMS1 ARHGEF7 ANO6 RP1L1 PKHD1 KCNQ1 COBL PLD1 CPLANE1 ARHGEF6 | 5.54e-06 | 685 | 143 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | ATP7A GDF2 TGFB2 C2CD3 AJAP1 SLC12A2 ALMS1 NFATC4 HS2ST1 PKHD1 LRP2 COBL CPLANE1 HECTD1 RNF207 FOXF1 | 6.41e-06 | 619 | 143 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | neuron development | BOC SETX ATP7A KREMEN1 EPHA6 RB1 ITGA6 THOC2 TGFB2 PPP3CA ALMS1 NFATC4 RP1L1 KNDC1 LRP2 KCNQ1 COBL ELAVL4 TRPM1 HERC1 CTNND2 TNR SDK1 VPS13B PLXNA2 TBCD | 7.86e-06 | 1463 | 143 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | response to wounding | EPPK1 ATP7A KREMEN1 EPB41L4B CD109 MUC16 DGKQ DGKD DGKH TGFB2 PPP3CA AJAP1 SLC12A2 ANO6 TNR FOXF1 | 1.40e-05 | 659 | 143 | 16 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 2.11e-05 | 217 | 143 | 9 | GO:1903034 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.82e-05 | 126 | 143 | 7 | GO:1903035 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | GDF2 TGFB2 C2CD3 SLC12A2 NFATC4 HS2ST1 PKHD1 LRP2 COBL HECTD1 RNF207 FOXF1 | 3.82e-05 | 421 | 143 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 5.17e-05 | 11 | 143 | 3 | GO:0046834 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | ATP7A GDF2 TGFB2 C2CD3 AJAP1 SLC12A2 ALMS1 NFATC4 HS2ST1 PKHD1 LRP2 COBL CPLANE1 HECTD1 RNF207 FOXF1 | 6.61e-05 | 750 | 143 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | neuron projection development | BOC SETX ATP7A KREMEN1 EPHA6 RB1 ITGA6 THOC2 TGFB2 PPP3CA ALMS1 NFATC4 KNDC1 LRP2 COBL ELAVL4 HERC1 CTNND2 TNR SDK1 VPS13B PLXNA2 | 7.53e-05 | 1285 | 143 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 1.10e-04 | 36 | 143 | 4 | GO:0006654 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.43e-04 | 3 | 143 | 2 | GO:0071691 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 1.54e-04 | 73 | 143 | 5 | GO:0001738 | |
| GeneOntologyBiologicalProcess | sensory perception | SPATA7 DMXL2 RTP2 OR5B21 OR14I1 TAAR5 OR1L3 TULP2 TGFBI SLC12A2 ALMS1 RP1L1 OR1E2 LRP2 OR1G1 KCNQ1 TRPM1 OLFM2 SLC24A1 | 1.57e-04 | 1072 | 143 | 19 | GO:0007600 |
| GeneOntologyBiologicalProcess | wound healing | EPPK1 EPB41L4B CD109 MUC16 DGKQ DGKD DGKH TGFB2 PPP3CA AJAP1 SLC12A2 ANO6 | 1.70e-04 | 493 | 143 | 12 | GO:0042060 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ABCB7 SETX ATP7A RB1 ITGA6 TOGARAM1 DGKD UFL1 SAXO1 GDF2 SH2B1 TGFB2 PPP3CA ALMS1 ARHGEF7 ANO6 NAV3 LRP2 COBL ELAVL4 ADGRL2 PLXNA2 | 1.82e-04 | 1366 | 143 | 22 | GO:0051130 |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 1.84e-04 | 41 | 143 | 4 | GO:0046473 | |
| GeneOntologyBiologicalProcess | epithelium development | EPPK1 ATP7A RBBP6 CD109 GDF2 POF1B TGFB2 C2CD3 PPP3CA AJAP1 SLC12A2 ALMS1 NFATC4 HS2ST1 PKHD1 LRP2 KCNQ1 COBL CPLANE1 HECTD1 RNF207 PLXNA2 FOXF1 | 1.93e-04 | 1469 | 143 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | NPR3 SDK2 ATP7A NEBL CD109 NEB GDF2 TERT TGFB2 SLC12A2 NFATC4 SPACA1 HS2ST1 KNDC1 LRP2 COBL HERC1 HECTD1 EIF2AK3 SDK1 VPS13B PLXNA2 FOXF1 | 2.21e-04 | 1483 | 143 | 23 | GO:0048646 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | BOC ATP7A EPHA6 RB1 TGFB2 PPP3CA NFATC4 KNDC1 LRP2 COBL ELAVL4 CTNND2 TNR PLXNA2 TBCD | 2.22e-04 | 748 | 143 | 15 | GO:0048667 |
| MousePheno | abnormal renal tubule epithelial cell primary cilium morphology | 8.97e-06 | 16 | 121 | 4 | MP:0011066 | |
| MousePheno | abnormal nonmotile primary cilium morphology | 3.10e-05 | 70 | 121 | 6 | MP:0013205 | |
| MousePheno | abnormal kidney epithelial cell primary cilium morphology | 4.16e-05 | 23 | 121 | 4 | MP:0011065 | |
| MousePheno | abnormal renal tubule epithelium morphology | 5.69e-05 | 48 | 121 | 5 | MP:0009640 | |
| MousePheno | abnormal primary cilium morphology | 5.85e-05 | 114 | 121 | 7 | MP:0013203 | |
| MousePheno | abnormal interdental cell morphology | 7.43e-05 | 2 | 121 | 2 | MP:0004482 | |
| Domain | DAGK_acc | 5.28e-05 | 10 | 145 | 3 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 5.28e-05 | 10 | 145 | 3 | IPR000756 | |
| Domain | DAGKa | 5.28e-05 | 10 | 145 | 3 | SM00045 | |
| Domain | DAGKc | 1.57e-04 | 14 | 145 | 3 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.95e-04 | 15 | 145 | 3 | IPR001206 | |
| Domain | DAGK | 1.95e-04 | 15 | 145 | 3 | PS50146 | |
| Domain | DAGK_cat | 1.95e-04 | 15 | 145 | 3 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 2.88e-04 | 17 | 145 | 3 | IPR016064 | |
| Domain | ARM-type_fold | USP24 TOGARAM1 RALGAPA2 THADA MROH8 CTNND2 HECTD1 TBCD ARMC6 XPO7 | 3.22e-04 | 339 | 145 | 10 | IPR016024 |
| Domain | Nebulin | 3.56e-04 | 4 | 145 | 2 | PF00880 | |
| Domain | NEBULIN | 3.56e-04 | 4 | 145 | 2 | PS51216 | |
| Domain | NEBU | 3.56e-04 | 4 | 145 | 2 | SM00227 | |
| Domain | Nebulin | 3.56e-04 | 4 | 145 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 3.56e-04 | 4 | 145 | 2 | IPR000900 | |
| Domain | GPCR_2_latrophilin | 5.89e-04 | 5 | 145 | 2 | IPR003924 | |
| Domain | HMG_box | 7.60e-04 | 53 | 145 | 4 | PF00505 | |
| Domain | HMG_BOX_2 | 8.15e-04 | 54 | 145 | 4 | PS50118 | |
| Domain | HMG | 8.15e-04 | 54 | 145 | 4 | SM00398 | |
| Domain | - | 8.74e-04 | 55 | 145 | 4 | 1.10.30.10 | |
| Domain | C1_1 | 1.00e-03 | 57 | 145 | 4 | PF00130 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.31e-05 | 27 | 104 | 4 | M12123 | |
| Pubmed | SPATA7 GAPVD1 SETX ATP7A EPB41L4B MUC16 THADA PPP3CA BBX SLC12A2 ANO6 MKI67 PLD1 ADGRL2 MGA SDK1 XPO7 | 3.64e-08 | 777 | 147 | 17 | 35844135 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 23949095 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 ABCB7 SETX ESS2 RB1 UFL1 CIC SH2B1 BBX PHF20L1 NFATC4 ADGRL2 MGA EIF2AK3 FOXF1 ARMC6 XPO7 | 1.47e-07 | 857 | 147 | 17 | 25609649 |
| Pubmed | SECISBP2L DMXL2 TOGARAM1 DGKD RALGAPA2 GALNT16 SH2B1 THADA ALMS1 ADGRF5 MGA HECTD1 | 1.37e-06 | 493 | 147 | 12 | 15368895 | |
| Pubmed | DMXL2 CTU2 GAPVD1 ESS2 ITGA6 UFL1 TUBGCP2 POF1B CIC THADA TADA2B MGA FOXF1 TBCD | 1.49e-06 | 689 | 147 | 14 | 36543142 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ATP7A SRSF2 EPB41L4B DGKD RALGAPA2 THADA SLC12A2 ARHGEF7 EIF2B1 CENPI COBL PLD1 HERC1 TBCD | 2.44e-06 | 719 | 147 | 14 | 35337019 |
| Pubmed | DLGAP1 SETX RBBP6 NEB LCP2 CIC ARHGEF7 NAV3 COBL CPLANE1 MGA | 7.62e-06 | 486 | 147 | 11 | 20936779 | |
| Pubmed | A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. | 8.69e-06 | 10 | 147 | 3 | 22961080 | |
| Pubmed | Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling. | 8.69e-06 | 10 | 147 | 3 | 19710169 | |
| Pubmed | DMXL2 ATP7A SLC35E1 ITGA6 SLC12A2 ANO6 LRP2 PLD1 ADGRL2 EIF2AK3 VPS13B | 1.07e-05 | 504 | 147 | 11 | 34432599 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GAPVD1 TMEM59 USP24 RDH14 SLC35E1 UFL1 DCAF16 TUBGCP2 THADA SLC12A2 HS2ST1 ADGRL2 HECTD1 TBCD XPO7 | 1.18e-05 | 942 | 147 | 15 | 31073040 |
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 17021016 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPR3 ABCB7 TMEM59 CD109 SLC35E1 ITGA6 TGFB2 TMX2 TGFBI IGSF10 THADA PTPN12 SLC12A2 ANO6 HS2ST1 HECTD1 EIF2AK3 | 1.39e-05 | 1201 | 147 | 17 | 35696571 |
| Pubmed | Identification and characterization of two splice variants of human diacylglycerol kinase eta. | 1.77e-05 | 2 | 147 | 2 | 12810723 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9438377 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.77e-05 | 2 | 147 | 2 | 15213259 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.77e-05 | 2 | 147 | 2 | 15703275 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30150416 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28150740 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34792732 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19851499 | ||
| Pubmed | The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. | 1.77e-05 | 2 | 147 | 2 | 15679862 | |
| Pubmed | Conservation of hearing by simultaneous mutation of Na,K-ATPase and NKCC1. | 1.77e-05 | 2 | 147 | 2 | 17674100 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 8626538 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17111813 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.77e-05 | 2 | 147 | 2 | 12230981 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21426709 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 35187889 | ||
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.77e-05 | 2 | 147 | 2 | 27644106 | |
| Pubmed | 2.05e-05 | 13 | 147 | 3 | 26878215 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 3.03e-05 | 42 | 147 | 4 | 11439183 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.10e-05 | 208 | 147 | 7 | 33230847 | |
| Pubmed | SLC7A13 NEBL STXBP5L VPS50 DGKH RALGAPA2 IGSF10 PHF20L1 ELAVL4 PLD1 NCR2 VPS13B | 3.75e-05 | 686 | 147 | 12 | 29987050 | |
| Pubmed | 3.98e-05 | 16 | 147 | 3 | 29559301 | ||
| Pubmed | USP40 deubiquitinates HINT1 and stabilizes p53 in podocyte damage. | 3.99e-05 | 45 | 147 | 4 | 35605301 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.37e-05 | 91 | 147 | 5 | 28558017 | |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 4.56e-05 | 221 | 147 | 7 | 31950832 | |
| Pubmed | 4.82e-05 | 17 | 147 | 3 | 34622152 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GAPVD1 ABCB7 DSG1 RB1 RBBP6 SLC35E1 ITGA6 THOC2 TMX2 ZNF263 SLC12A2 CENPI MKI67 MGA TBCD XPO7 | 5.31e-05 | 1203 | 147 | 16 | 29180619 |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25675863 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 34724040 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 27163153 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23294542 | ||
| Pubmed | Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome. | 5.31e-05 | 3 | 147 | 2 | 25965571 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12508351 | ||
| Pubmed | Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. | 5.31e-05 | 3 | 147 | 2 | 12799190 | |
| Pubmed | Biomarkers distinguishing mammary fibroepithelial neoplasms: a tissue microarray study. | 5.31e-05 | 3 | 147 | 2 | 25003838 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16619045 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12032846 | ||
| Pubmed | RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. | 5.31e-05 | 3 | 147 | 2 | 9582122 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 33559030 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 10896674 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15308640 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12499048 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28965621 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 21094218 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 20700529 | ||
| Pubmed | [Expression and significance of hTERT, c-myc and Ki-67 in hepatocellular carcinoma]. | 5.31e-05 | 3 | 147 | 2 | 19351506 | |
| Pubmed | The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. | 5.31e-05 | 3 | 147 | 2 | 9178770 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23407945 | ||
| Pubmed | The HBP1 transcriptional repressor participates in RAS-induced premature senescence. | 5.31e-05 | 3 | 147 | 2 | 16966377 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23859194 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 21572399 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 22164265 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 5.49e-05 | 400 | 147 | 9 | 35013556 | |
| Pubmed | 5.76e-05 | 18 | 147 | 3 | 24068962 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPHA6 EPB41L4B HEBP2 STXBP5L DGKH SH2B1 THADA PPP3CA HS2ST1 KNDC1 CDYL2 COBL OLFM2 HECTD1 VPS13B TBCD PDZD2 XPO7 | 6.08e-05 | 1489 | 147 | 18 | 28611215 |
| Pubmed | GAPVD1 ESS2 NEBL VPS50 SLC35E1 TUBGCP2 SLC12A2 ALMS1 NFATC4 EIF2B1 MGA HECTD1 | 7.06e-05 | 733 | 147 | 12 | 34672954 | |
| Pubmed | 7.20e-05 | 101 | 147 | 5 | 9872452 | ||
| Pubmed | ATP7A EPB41L4B ITGA6 UFL1 RALGAPA2 ZDHHC20 SLC12A2 COBL ADGRL2 | 8.11e-05 | 421 | 147 | 9 | 36976175 | |
| Pubmed | RB1 RBBP6 VPS50 DCAF16 TUBGCP2 RALGAPA2 THADA ALMS1 TADA2B INTS11 LRP2 PLD1 ADGRL2 MGA ARMC6 | 8.18e-05 | 1116 | 147 | 15 | 31753913 | |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 8.84e-05 | 55 | 147 | 4 | 38945485 | |
| Pubmed | GAPVD1 SDK2 SETX VPS50 UFL1 ARHGEF7 HS2ST1 HMGXB3 ATP1A2 ADGRL2 | 9.01e-05 | 529 | 147 | 10 | 14621295 | |
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 9.30e-05 | 21 | 147 | 3 | 27591083 | |
| Pubmed | 9.30e-05 | 21 | 147 | 3 | 28107452 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.52e-05 | 430 | 147 | 9 | 35044719 | |
| Pubmed | PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. | 1.06e-04 | 4 | 147 | 2 | 9659915 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 10428811 | ||
| Pubmed | The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade. | 1.06e-04 | 4 | 147 | 2 | 15649357 | |
| Pubmed | Upper aerodigestive tract squamous dysplasia: correlation with p16, p53, pRb, and Ki-67 expression. | 1.06e-04 | 4 | 147 | 2 | 16948516 | |
| Pubmed | Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. | 1.06e-04 | 4 | 147 | 2 | 23812757 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 16901941 | ||
| Pubmed | Differential expression of cyclin D1, Ki‑67, pRb, and p53 in psoriatic skin lesions and normal skin. | 1.06e-04 | 4 | 147 | 2 | 29115643 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 19587023 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 12499396 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 17442359 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 12935897 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 17229811 | ||
| Pubmed | Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix. | 1.06e-04 | 4 | 147 | 2 | 15306850 | |
| Pubmed | Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin. | 1.06e-04 | 4 | 147 | 2 | 11309392 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 23985323 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 27182061 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 27307045 | ||
| Pubmed | SHP-2 and PTP-pest induction during Rb-E2F associated apoptosis. | 1.06e-04 | 4 | 147 | 2 | 22644489 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 19570895 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 21725308 | ||
| Pubmed | 1.08e-04 | 176 | 147 | 6 | 28692057 | ||
| Pubmed | 1.21e-04 | 347 | 147 | 8 | 17114649 | ||
| Pubmed | 1.23e-04 | 23 | 147 | 3 | 19864318 | ||
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 1.23e-04 | 23 | 147 | 3 | 24360543 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.09e-05 | 10 | 103 | 3 | 1178 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.16e-03 | 206 | 103 | 6 | 682 | |
| GeneFamily | Olfactory receptors, family 1 | 1.52e-03 | 40 | 103 | 3 | 147 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.88e-03 | 43 | 103 | 3 | 409 | |
| GeneFamily | Fibronectin type III domain containing | 2.22e-03 | 160 | 103 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.28e-03 | 161 | 103 | 5 | 593 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.14e-07 | 145 | 144 | 9 | M1810 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L CDK17 DMXL2 GAPVD1 SETX RB1 USP24 ITGA6 TOGARAM1 THOC2 TGFB2 C2CD3 PTPN12 BBX ARHGEF7 MTMR3 NAV3 VPS13B | 1.15e-06 | 856 | 144 | 18 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | GAPVD1 USP24 TOGARAM1 BBX AJAP1 ARHGEF7 MKI67 NAV3 ADGRL2 VPS13B | 6.61e-06 | 300 | 144 | 10 | M8702 |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 1.44e-05 | 198 | 144 | 8 | M9346 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.30e-05 | 289 | 144 | 9 | M2196 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | DMXL2 ATP7A ITGA6 NEB THOC2 RASGRP1 SLC12A2 SPACA1 ARHGEF7 HERC1 CPLANE1 MGA DYNC1I1 ZNF541 | 2.63e-07 | 387 | 139 | 14 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 2.87e-06 | 134 | 139 | 8 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DMXL2 GAPVD1 ATP7A ITGA6 DGKD THOC2 TULP2 RASGRP1 PTPN12 BBX SLC12A2 ALMS1 SPACA1 HERC1 CPLANE1 MGA DYNC1I1 ZNF541 | 3.27e-06 | 776 | 139 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.03e-06 | 110 | 139 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | NPR3 NEBL EPB41L4B HEBP2 RBBP6 CD109 GLIS3 ITGA6 POF1B TGFB2 C2CD3 NFATC4 NAV3 TRPM1 CTNND2 CPLANE1 DYNC1I1 | 1.17e-05 | 769 | 139 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DMXL2 ATP7A ITGA6 DGKD NEB THOC2 TULP2 RASGRP1 BBX SLC12A2 SPACA1 ARHGEF7 HERC1 CPLANE1 MGA DYNC1I1 ZNF541 | 1.36e-05 | 778 | 139 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DMXL2 GAPVD1 ATP7A ITGA6 THOC2 TULP2 RASGRP1 BBX SLC12A2 SPACA1 ARHGEF7 HERC1 CPLANE1 MGA DYNC1I1 ZNF541 | 6.62e-05 | 795 | 139 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.40e-04 | 230 | 139 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.14e-07 | 174 | 146 | 8 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-07 | 186 | 146 | 8 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-07 | 186 | 146 | 8 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-07 | 189 | 146 | 8 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.52e-07 | 193 | 146 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.52e-07 | 193 | 146 | 8 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-07 | 194 | 146 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.83e-07 | 196 | 146 | 8 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.95e-07 | 197 | 146 | 8 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-07 | 198 | 146 | 8 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.30e-07 | 200 | 146 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-06 | 167 | 146 | 7 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-06 | 180 | 146 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.22e-06 | 180 | 146 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.22e-06 | 180 | 146 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-06 | 180 | 146 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 184 | 146 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 184 | 146 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 184 | 146 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 2.85e-06 | 187 | 146 | 7 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-06 | 188 | 146 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 3.17e-06 | 190 | 146 | 7 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.17e-06 | 190 | 146 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.17e-06 | 190 | 146 | 7 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.17e-06 | 190 | 146 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-06 | 193 | 146 | 7 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-06 | 193 | 146 | 7 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-06 | 194 | 146 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 194 | 146 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-06 | 194 | 146 | 7 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 195 | 146 | 7 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 195 | 146 | 7 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.89e-06 | 196 | 146 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 3.89e-06 | 196 | 146 | 7 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.02e-06 | 197 | 146 | 7 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-06 | 197 | 146 | 7 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 198 | 146 | 7 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 198 | 146 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 4.30e-06 | 199 | 146 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.44e-06 | 200 | 146 | 7 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.44e-06 | 200 | 146 | 7 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.44e-06 | 200 | 146 | 7 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.44e-06 | 200 | 146 | 7 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.44e-06 | 200 | 146 | 7 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.44e-06 | 200 | 146 | 7 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.44e-06 | 200 | 146 | 7 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.44e-06 | 200 | 146 | 7 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.44e-06 | 200 | 146 | 7 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.44e-06 | 200 | 146 | 7 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.63e-06 | 139 | 146 | 6 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 156 | 146 | 6 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 166 | 146 | 6 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 166 | 146 | 6 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 167 | 146 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.95e-05 | 168 | 146 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 170 | 146 | 6 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 174 | 146 | 6 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 175 | 146 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 175 | 146 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 176 | 146 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 177 | 146 | 6 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.79e-05 | 179 | 146 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.79e-05 | 179 | 146 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.79e-05 | 179 | 146 | 6 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.88e-05 | 180 | 146 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.88e-05 | 180 | 146 | 6 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.97e-05 | 181 | 146 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.97e-05 | 181 | 146 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.06e-05 | 182 | 146 | 6 | bb1f815718397de96682697fcbd6014a992a28f7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 183 | 146 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 183 | 146 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 3.25e-05 | 184 | 146 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 3.35e-05 | 185 | 146 | 6 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 186 | 146 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 187 | 146 | 6 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.67e-05 | 188 | 146 | 6 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.67e-05 | 188 | 146 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 188 | 146 | 6 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 188 | 146 | 6 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.78e-05 | 189 | 146 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.78e-05 | 189 | 146 | 6 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-05 | 190 | 146 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.89e-05 | 190 | 146 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 190 | 146 | 6 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.89e-05 | 190 | 146 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.46e-06 | 193 | 146 | 9 | 4834_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 5.27e-06 | 197 | 146 | 9 | 5796_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 5.96e-06 | 200 | 146 | 9 | 2265_UP | |
| Disease | body weight | SECISBP2L CDK17 GAPVD1 NPR3 EPHA6 EPB41L4B DGKH SH2B1 TGFB2 SLC12A2 NFATC4 ARHGEF7 SPHKAP MTMR3 KCNQ1 ITIH6 MGA EIF2AK3 PDZD2 XPO7 | 2.50e-06 | 1261 | 141 | 20 | EFO_0004338 |
| Disease | creatinine measurement, glomerular filtration rate | 2.17e-05 | 117 | 141 | 6 | EFO_0004518, EFO_0005208 | |
| Disease | creatinine measurement | SPATA7 GAPVD1 SLC7A13 RDH14 GLIS3 DGKH NEB PTPN12 PPP3CA ALMS1 MTMR3 PKHD1 LRP2 KCNQ1 DLEC1 ADGRL2 | 2.32e-05 | 995 | 141 | 16 | EFO_0004518 |
| Disease | Cri-du-Chat Syndrome | 6.78e-05 | 3 | 141 | 2 | C0010314 | |
| Disease | Gastrointestinal Stromal Sarcoma | 7.60e-05 | 47 | 141 | 4 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 9.70e-05 | 50 | 141 | 4 | C0238198 | |
| Disease | kidney disease (biomarker_via_orthology) | 1.33e-04 | 21 | 141 | 3 | DOID:557 (biomarker_via_orthology) | |
| Disease | small cell carcinoma (is_implicated_in) | 1.35e-04 | 4 | 141 | 2 | DOID:0050685 (is_implicated_in) | |
| Disease | Alzheimer disease, p-tau measurement | 1.35e-04 | 4 | 141 | 2 | EFO_0004763, MONDO_0004975 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.76e-04 | 23 | 141 | 3 | C0018784 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.54e-04 | 64 | 141 | 4 | DOID:4947 (is_marker_for) | |
| Disease | pancreatic ductal adenocarcinoma (is_marker_for) | 2.87e-04 | 27 | 141 | 3 | DOID:3498 (is_marker_for) | |
| Disease | macula measurement | 3.06e-04 | 189 | 141 | 6 | EFO_0008375 | |
| Disease | Progressive supranuclear palsy | 3.36e-04 | 6 | 141 | 2 | C0038868 | |
| Disease | Ophthalmoplegia, Progressive Supranuclear | 3.36e-04 | 6 | 141 | 2 | C4551862 | |
| Disease | Supranuclear Palsy, Progressive, 1 | 3.36e-04 | 6 | 141 | 2 | C4551863 | |
| Disease | facial morphology measurement | 4.21e-04 | 466 | 141 | 9 | EFO_0007841 | |
| Disease | sensorineural hearing loss (biomarker_via_orthology) | 6.23e-04 | 8 | 141 | 2 | DOID:10003 (biomarker_via_orthology) | |
| Disease | age at onset, coronary stenosis | 7.98e-04 | 9 | 141 | 2 | EFO_0004847, MONDO_0006715 | |
| Disease | vital capacity | EPB41L4B RDH14 GLIS3 DCAF16 SH2B1 TGFB2 ZNF263 NFATC4 MTMR3 LRP2 ADGRL2 EIF2AK3 ARHGEF6 DYNC1I1 PDZD2 | 8.68e-04 | 1236 | 141 | 15 | EFO_0004312 |
| Disease | multisite chronic pain | 1.14e-03 | 95 | 141 | 4 | EFO_0010100 | |
| Disease | ejection fraction measurement | 1.15e-03 | 43 | 141 | 3 | EFO_0005527 | |
| Disease | neutropenia, response to gemcitabine | 1.21e-03 | 11 | 141 | 2 | GO_0036272, MONDO_0001475 | |
| Disease | smoking behavior | 1.31e-03 | 341 | 141 | 7 | EFO_0004318 | |
| Disease | hydroxy-leucine measurement | 1.31e-03 | 45 | 141 | 3 | EFO_0005276 | |
| Disease | spontaneous preterm birth | 1.42e-03 | 101 | 141 | 4 | EFO_0006917 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.45e-03 | 12 | 141 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.45e-03 | 12 | 141 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.45e-03 | 12 | 141 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.45e-03 | 12 | 141 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.45e-03 | 12 | 141 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.45e-03 | 12 | 141 | 2 | C1848172 | |
| Disease | tonsillectomy risk measurement | 1.61e-03 | 260 | 141 | 6 | EFO_0007924 | |
| Disease | amyloid-beta measurement | 1.64e-03 | 355 | 141 | 7 | EFO_0005194 | |
| Disease | Hepatic fibrosis | 1.68e-03 | 49 | 141 | 3 | HP_0001395 | |
| Disease | susceptibility to measles measurement | 1.68e-03 | 49 | 141 | 3 | EFO_0008414 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.71e-03 | 13 | 141 | 2 | C4041558 | |
| Disease | T wave morphology measurement | 1.99e-03 | 14 | 141 | 2 | EFO_0008398 | |
| Disease | waist-hip ratio | DMXL2 NPR3 EPB41L4B DGKQ LCP2 SH2B1 THADA BBX NAV3 CDYL2 ADGRF5 DLEC1 OLFM2 PLD1 | 2.27e-03 | 1226 | 141 | 14 | EFO_0004343 |
| Disease | Cleft palate, cleft lip | 2.29e-03 | 279 | 141 | 6 | EFO_0003959, HP_0000175 | |
| Disease | Varicose veins | 2.40e-03 | 193 | 141 | 5 | HP_0002619 | |
| Disease | Tremor, Rubral | 2.60e-03 | 16 | 141 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.60e-03 | 16 | 141 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.60e-03 | 16 | 141 | 2 | C0278161 | |
| Disease | coronary thrombosis, GM11992 | 2.60e-03 | 16 | 141 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | Ataxia, Sensory | 2.60e-03 | 16 | 141 | 2 | C0240991 | |
| Disease | Abnormal coordination | 2.60e-03 | 16 | 141 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 2.60e-03 | 16 | 141 | 2 | C0427190 | |
| Disease | Night blindness, congenital stationary | 2.94e-03 | 17 | 141 | 2 | C0339535 | |
| Disease | response to opioid | 3.14e-03 | 61 | 141 | 3 | EFO_0008541 | |
| Disease | Adrenocortical carcinoma | 3.30e-03 | 18 | 141 | 2 | C0206686 | |
| Disease | urolithiasis | 3.44e-03 | 63 | 141 | 3 | MONDO_0024647 | |
| Disease | Disorder of eye | 3.58e-03 | 212 | 141 | 5 | C0015397 | |
| Disease | hemoglobin A1 measurement | 3.62e-03 | 520 | 141 | 8 | EFO_0007629 | |
| Disease | telomere length | 4.03e-03 | 313 | 141 | 6 | EFO_0004505 | |
| Disease | eye colour measurement | 4.03e-03 | 218 | 141 | 5 | EFO_0009764 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 4.07e-03 | 20 | 141 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | polymyositis | 4.07e-03 | 20 | 141 | 2 | EFO_0003063 | |
| Disease | Microcephaly | 4.09e-03 | 67 | 141 | 3 | C0025958 | |
| Disease | Sarcoma | 4.49e-03 | 21 | 141 | 2 | C1261473 | |
| Disease | in situ carcinoma (is_marker_for) | 4.49e-03 | 21 | 141 | 2 | DOID:8719 (is_marker_for) | |
| Disease | nose morphology measurement, mouth morphology measurement | 4.49e-03 | 21 | 141 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | disease | 4.49e-03 | 21 | 141 | 2 | EFO_0000408 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTTQLYTDRTEKLRP | 116 | Q15582 | |
| RKFYTNSRTTIESPS | 1301 | Q68DN1 | |
| SSSAYIAVPTLQTDR | 71 | Q9N2J8 | |
| SNYVREIKSSERPLS | 211 | Q15052 | |
| YSASSKIIISDVPSR | 411 | Q8WY36 | |
| YLQSSVRISEKFPSS | 396 | Q9NZJ5 | |
| SVASSRPQEVSAYLT | 101 | Q6NXE6 | |
| LTSKLVLVSPTSEQY | 61 | O00178 | |
| VLSSPRKTAQDTLYV | 691 | O95267 | |
| SVSSSLYSYREKPIV | 1706 | Q8TCU4 | |
| VTSTSYSHREKPIVS | 1801 | Q8TCU4 | |
| YGPTTVSILQTRKTT | 201 | Q9UKB5 | |
| AYVSVRVTPKSTARS | 411 | P52824 | |
| VSINKESSRVYLTDP | 756 | O95490 | |
| ARRESYLKATQPSLT | 371 | O14490 | |
| TIKVSYARPSSASIR | 121 | P26378 | |
| TYLRPLQTSEKLSSA | 296 | Q14155 | |
| TSYRISEESTKIPQS | 1441 | Q8TDJ6 | |
| SYVQLTSRALPSLTD | 141 | Q7Z5J1 | |
| RLAKSYSTSSPINIV | 306 | Q9UQB3 | |
| VKETTRTEPINTTYS | 186 | Q9NXF7 | |
| YSSLQTVTLLRTVKP | 316 | P17342 | |
| YNASSVTPESLRKAI | 321 | Q04656 | |
| VSYSSDLPATSVIIT | 116 | Q8N428 | |
| IPTIVASSNLRVYTS | 306 | Q9ULI1 | |
| LIYLTQPSSSISTEI | 171 | P06400 | |
| PLSSVLEQYKADTRT | 131 | O95897 | |
| LYSSKDTTKRPVTTT | 251 | Q9BQ51 | |
| YTSDKSTTPASNIVR | 96 | Q9UK05 | |
| YLTPQTATSITASII | 501 | Q4KMQ2 | |
| YITSTAQTTSLVSLP | 3451 | Q8WXI7 | |
| TPLATTQRFTYSEKT | 4121 | Q8WXI7 | |
| PYKELTGATTEVSRT | 4916 | Q8WXI7 | |
| PYKTRNITVFRQTST | 481 | Q6W4X9 | |
| YSSAVAPKTVAALRS | 71 | A6NL26 | |
| YDSSVRKSPTLLEVS | 461 | P51787 | |
| TVREAPQIYSLSSSS | 126 | Q4G0X4 | |
| KSVRFYLVVSPASAS | 121 | O95944 | |
| PRTTVKDSDITATYK | 216 | O60721 | |
| QLPTKSTSYVRTLDS | 856 | Q8IWI9 | |
| RPNLLITESTYATTI | 196 | Q5TA45 | |
| SESTITISLYIPSEQ | 101 | Q9Y5Z4 | |
| TKSYPVTRSEATAAT | 1446 | Q5HYC2 | |
| SAQSEIRTISAYKTP | 1376 | Q14C86 | |
| TSPNYRLIKSRSESD | 1501 | Q15751 | |
| REVVSYSKETQTPLA | 161 | O14576 | |
| ENPTSIKLTTTYTRR | 296 | Q12766 | |
| KRFSVYVTESQPDLS | 146 | Q14232 | |
| DRSVVALVPKQTSSY | 1591 | O75051 | |
| KLEYTVRTDTQSPTN | 1086 | O15018 | |
| SSVSSYSNITVPSRK | 906 | Q8IVL0 | |
| ARSSKVLYVITTSPS | 351 | Q96MU8 | |
| TKNTATTSPITYTLV | 91 | Q9UQV4 | |
| LLQKNRTPYVTTTVS | 31 | Q9BSJ2 | |
| YSTNPRTQSIEVLTL | 1836 | P98164 | |
| RAKSVPTKTYSNEVV | 336 | Q00537 | |
| VRVTVFPSKTVAQYS | 1036 | P23229 | |
| KTTKVSYRASQPDLV | 1731 | P46013 | |
| SSLKSVQTREPYEVA | 151 | Q86XP1 | |
| INTVSLFISRPKYTD | 406 | Q9H579 | |
| TTTRDNENIYSTKIP | 281 | Q2PPJ7 | |
| SREVLSPLKTTSSYQ | 71 | Q8WVV4 | |
| SPSTARSRITKYSTV | 1031 | Q02413 | |
| STYYNPSLKSRVTIS | 76 | P0DP08 | |
| KSTSKTYVISRTEPA | 81 | Q7Z6E9 | |
| ISYTNVFSTILKIPS | 216 | P47890 | |
| PALQRLVSRTASKYT | 396 | Q96DF8 | |
| KSIAYTLTSNIPEIT | 771 | P50993 | |
| YTTVLKPSLNFTATV | 356 | Q6YHK3 | |
| TTSFLLKVYVPQSRV | 221 | Q02985 | |
| TVVRKVDATDASYPS | 2561 | Q9ULT8 | |
| KTTPTIKYFRTEISQ | 1121 | Q6WRI0 | |
| SSSQTIYPGIKARIT | 21 | Q8NFQ6 | |
| IILSSPRTSKTDSYE | 476 | Q9BWV1 | |
| LQTEPKAVRTTTRYA | 81 | Q4AC94 | |
| ARAKSIPSQTYSSEV | 246 | Q96Q40 | |
| ESSSEYSPVIRVKTS | 1766 | Q9H799 | |
| FNTIIRTSPTSLVAY | 161 | Q8NEA6 | |
| TTEVTFLKPQRRTSS | 851 | O75128 | |
| YDTPVLVSRNTEKRS | 11 | O14645 | |
| TVTTDKPRAYTITIS | 1146 | Q6UXX5 | |
| YEAKLPRQASSSTVT | 451 | Q16760 | |
| YNRSSPVHIIATSKS | 131 | O60381 | |
| QDPTSTFTKIYRRSL | 1306 | Q76NI1 | |
| SLSVIPVLNSSSYTK | 306 | Q92674 | |
| PISSLRTTSYTIDQA | 1241 | Q9Y238 | |
| VKDIPRSATSYTLSL | 1951 | Q7Z5N4 | |
| TSTYLAVTSIAPNIT | 391 | Q58EX2 | |
| STPEVQSEQSSVRYK | 256 | Q9HBV2 | |
| STVQTIYTTRKPVSL | 861 | Q9H329 | |
| IYTTRKPVSLAASAE | 866 | Q9H329 | |
| YRKSQTTGFPSLITI | 291 | Q08209 | |
| QFPSTVSTVYRTSEK | 356 | Q2VPK5 | |
| SRLPKTRSYDNLTTA | 606 | Q13615 | |
| SYARIVSSILKVPSS | 226 | P47887 | |
| QLTLSYSKTVSEDRP | 106 | A6NNC1 | |
| TEKTTTYQYPRAILS | 616 | A8MW92 | |
| EQLTYSSTRSKAPSV | 486 | Q9UF33 | |
| QPLSSYTVKDRIATI | 261 | Q8NH93 | |
| YISVTVPKSIRNSLT | 71 | A6ND48 | |
| IQSSPTKRLTLSEIY | 61 | Q12946 | |
| VTTYTSEASKPRAQA | 176 | Q5QGT7 | |
| SQKVFSPQTRTVDLY | 321 | O14804 | |
| YLTTITKQITPYVRS | 526 | Q6ZRF8 | |
| SSDVVLVSYVPSSQR | 616 | Q9NRF2 | |
| KEAALVLTRPNTYSS | 621 | Q2M3C7 | |
| LKVDNLTYRTSPDTL | 16 | Q01130 | |
| SYRLSTVVSPVIQSS | 956 | Q6YHU6 | |
| EIPFESLTTQKQSYR | 231 | Q8IYX7 | |
| SLNLSPARYVTVKTI | 361 | Q86TJ2 | |
| ISLKTTSDLVSRNYP | 321 | Q1RMZ1 | |
| LTLTVPEYSNKRVSR | 646 | Q14934 | |
| FTSTTRVPSINLYTI | 91 | Q13393 | |
| PFIKYSTRQALSTAT | 481 | P58107 | |
| IIYNRVPKTASTSFT | 76 | Q7LGA3 | |
| ATLYSRTQTPRAELK | 146 | P41222 | |
| SDINYQTRKTVSLTP | 556 | Q05209 | |
| IRNSSVRTKLEPESY | 331 | Q7Z333 | |
| ITNTRPLSYTVVTAA | 511 | Q93073 | |
| TYVSSLNPVIVTLSR | 1101 | P08F94 | |
| KTTTVNYVRDTLSNP | 2596 | P08F94 | |
| SSAPSRIVVVSSKLY | 181 | Q9HBH5 | |
| VSPLSYSVANATKRI | 286 | Q96K37 | |
| PDLTKRIRTSYQSLT | 716 | Q9Y2K9 | |
| TARAYQIPESLKSIT | 51 | O75027 | |
| ARTLYKSTLNIPTEE | 241 | P32247 | |
| RAVATKSPTAEEYTV | 51 | Q8IZF2 | |
| ATKTVSYRTTPSGLQ | 131 | Q8N8U2 | |
| VLLPSSTRITYVQSA | 996 | Q96RK0 | |
| DLTSPTQRYIDSKVV | 176 | P61812 | |
| ITSSSKITIPKQQRY | 366 | Q53H76 | |
| YSQTVSTASELRKPI | 766 | Q96JG6 | |
| DVSTRYKVSTSPLTK | 201 | Q9Y320 | |
| YPASSLVVVRSKTED | 291 | Q9BXS4 | |
| ARALPIYTTSASKTI | 111 | Q5W0Z9 | |
| RRSKTSNYLISLDPT | 326 | O00295 | |
| SNLSTEDYIKRVPSI | 786 | Q8NI27 | |
| SDLLRFPVKQLYTTS | 186 | Q8IWN7 | |
| TPTRDAVVTYTAESK | 266 | P55011 | |
| IASEVTVPKDRTSYT | 726 | Q92752 | |
| TSYSVLRRLTVQPKT | 341 | Q12815 | |
| PVSVSTSIKYADQQR | 71 | Q9P0W8 | |
| SIFKSSRPIYLASQE | 306 | Q8TCU3 | |
| KITRSHSTDIPYIVS | 1476 | Q7Z4N2 | |
| AVTLIKYVAPESTSS | 356 | Q49AG3 | |
| PTVATSVQSPYRSTK | 906 | Q9UPU5 | |
| YASSPVKTKTVTESR | 1016 | Q7Z7G8 | |
| TPEVTKAYITSRLES | 406 | Q9UIA9 | |
| FPLIRKTTASQVYET | 1121 | Q9BTW9 | |
| TRKSVPRNSLESAEY | 1476 | Q9Y4F4 | |
| TTSVRSYLPNTVTDA | 116 | O14746 | |
| AITRPTAVNSLISKY | 196 | O94874 | |
| KAVFVPDIYSRTQST | 241 | O94874 | |
| TKSYRRESILSSSPN | 1256 | Q9H0D2 | |
| PSKRALSRDTVQESY | 236 | O14978 | |
| LVRDSSKKTTTNPYV | 446 | Q13094 | |
| YSTIADTPEIQRIKT | 571 | O76041 | |
| RTPVVNLKYTSIVDT | 3906 | P20929 |